Real-world evaluation of attention deficit hyperactivity disorder symptoms and side effects in patients prescribed serdexmethylphenidate/dexmethylphenidate or other stimulants.

Front Pharmacol · 2026 · PMC13234466 · PMID 42256406

Europe PMC DOI

hedged sentence

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

approached significancep = 0.052so close (0.05 < p ≤ 0.1)

Differences in return of symptoms between SDX/d-MPH and AMP ER approached significance ( p = 0.052; Figure 1 ). 3.3.

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.